Literature DB >> 28377398

IL-27 enhances LPS-induced IL-1β in human monocytes and murine macrophages.

Carlene Petes1, Christopher Wynick1, Christina Guzzo1,2, Divya Mehta1, Sarah Logan1, Bruce W Banfield1, Sameh Basta1, Andrea Cooper3, Katrina Gee4.   

Abstract

IL-27 bridges innate and adaptive immunity by modulating cytokine production from myeloid cells and regulating Th cell differentiation. During bacterial infection, TLR4 triggering by LPS induces IL-27 production by monocytes and macrophages. We have previously shown that IL-27 can prime monocytes for LPS responsiveness by enhancing TLR4 expression and intracellular signaling. If unregulated, this could result in damaging inflammation, whereas on the other hand, this may also provide greater responses by inflammatory processes induced in response to bacterial pathogens. A key process in fine-tuning inflammatory responses is activation of the inflammasome, which ultimately results in IL-1β production. Herein, we investigated the molecular mechanisms by which IL-27 modulates LPS-induced IL-1β secretion in monocytes and macrophages. We found that when delivered simultaneously with LPS, IL-27 augments activation of caspase-1 and subsequent release of IL-1β. Furthermore, we determined that IL-27 primes cells for enhanced IL-1β production by up-regulating surface expression of TLR4 and P2X purinoceptor 7 (P2X7) for enhanced LPS and ATP signaling, respectively. These findings provide new evidence that IL-27 plays an important role in the proinflammatory capacity of monocytes and macrophages via enhancing IL-1β secretion levels triggered by dual LPS-ATP stimulation. © Society for Leukocyte Biology.

Entities:  

Keywords:  Toll-like receptor; inflammasome; inflammation; innate immunity; lipopolysaccharide

Mesh:

Substances:

Year:  2017        PMID: 28377398      PMCID: PMC6608054          DOI: 10.1189/jlb.3A0316-098R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  59 in total

1.  WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27.

Authors:  Stefan Pflanz; Linda Hibbert; Jeanine Mattson; Rency Rosales; Elena Vaisberg; J Fernando Bazan; Joseph H Phillips; Terrill K McClanahan; Rene de Waal Malefyt; Robert A Kastelein
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

2.  Development of Th1-type immune responses requires the type I cytokine receptor TCCR.

Authors:  Q Chen; N Ghilardi; H Wang; T Baker; M H Xie; A Gurney; I S Grewal; F J de Sauvage
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

3.  Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes.

Authors:  C B Grahames; A D Michel; I P Chessell; P P Humphrey
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

4.  ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood.

Authors:  D G Perregaux; P McNiff; R Laliberte; M Conklyn; C A Gabel
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

5.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

Authors:  Stefan Pflanz; Jackie C Timans; Jeanne Cheung; Rency Rosales; Holger Kanzler; Jonathan Gilbert; Linda Hibbert; Tatyana Churakova; Marilyn Travis; Elena Vaisberg; Wendy M Blumenschein; Jeanine D Mattson; Janet L Wagner; Wayne To; Sandra Zurawski; Terrill K McClanahan; Daniel M Gorman; J Fernando Bazan; Rene de Waal Malefyt; Donna Rennick; Robert A Kastelein
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

6.  Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release.

Authors:  J Michelle Kahlenberg; George R Dubyak
Journal:  Am J Physiol Cell Physiol       Date:  2003-12-24       Impact factor: 4.249

Review 7.  Understanding the pro- and anti-inflammatory properties of IL-27.

Authors:  Alejandro V Villarino; Elaine Huang; Christopher A Hunter
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

8.  Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development.

Authors:  Hermelijn H Smits; Astrid J van Beelen; Christina Hessle; Robert Westland; Esther de Jong; Eelco Soeteman; Agnes Wold; Eddy A Wierenga; Martien L Kapsenberg
Journal:  Eur J Immunol       Date:  2004-05       Impact factor: 5.532

9.  Maturation and release of interleukin-1beta by lipopolysaccharide-primed mouse Schwann cells require the stimulation of P2X7 receptors.

Authors:  Aurore Colomar; Vincent Marty; Chantal Médina; Chantal Combe; Patricia Parnet; Thierry Amédée
Journal:  J Biol Chem       Date:  2003-06-09       Impact factor: 5.157

10.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.

Authors:  Fabio Martinon; Kimberly Burns; Jürg Tschopp
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

View more
  14 in total

1.  The effects of CD14 and IL-27 on induction of endotoxin tolerance in human monocytes and macrophages.

Authors:  Carlene Petes; Victoria Mintsopoulos; Renée L Finnen; Bruce W Banfield; Katrina Gee
Journal:  J Biol Chem       Date:  2018-09-21       Impact factor: 5.157

2.  Ebi3 Prevents Trypanosoma cruzi-Induced Myocarditis by Dampening IFN-γ-Driven Inflammation.

Authors:  Tiago Silva Medina; Gabriela Gonçalves Oliveira; Maria Cláudia Silva; Bruna Araújo David; Grace Kelly Silva; Denise Morais Fonseca; Renata Sesti-Costa; Amanda Farage Frade; Monique Andrade Baron; Barbara Ianni; Alexandre Costa Pereira; Christophe Chevillard; Edécio Cunha-Neto; José Antonio Marin-Neto; João Santana Silva
Journal:  Front Immunol       Date:  2017-09-26       Impact factor: 7.561

3.  Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation.

Authors:  Ida Gregersen; Øystein Sandanger; Erik T Askevold; Ellen Lund Sagen; Kuan Yang; Sverre Holm; Turid M Pedersen; Mona Skjelland; Kirsten Krohg-Sørensen; Trond Vidar Hansen; Tuva Børresdatter Dahl; Kari Otterdal; Terje Espevik; Pål Aukrust; Arne Yndestad; Bente Halvorsen
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

4.  The interleukin-27 -964A>G polymorphism enhances sepsis-induced inflammatory responses and confers susceptibility to the development of sepsis.

Authors:  Junbing He; Quanfu Zhang; Wenying Zhang; Feng Chen; Tian Zhao; Yao Lin; Jia Li; Yansong Liu; Yuchun Liu; Yiming Shao
Journal:  Crit Care       Date:  2018-09-30       Impact factor: 9.097

Review 5.  IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer.

Authors:  Olena Kourko; Kyle Seaver; Natalya Odoardi; Sameh Basta; Katrina Gee
Journal:  Front Oncol       Date:  2019-10-01       Impact factor: 6.244

6.  Changes in interleukin-27 levels in patients with acute coronary syndrome and their clinical significance.

Authors:  Lin Zhang; Junfeng Zhang; Shaohong Su; Suyan Luo
Journal:  PeerJ       Date:  2019-01-04       Impact factor: 2.984

Review 7.  The Activated Macrophage - A Tough Fortress for Virus Invasion: How Viruses Strike Back.

Authors:  Andra Banete; Julia Barilo; Reese Whittaker; Sameh Basta
Journal:  Front Microbiol       Date:  2022-01-11       Impact factor: 5.640

Review 8.  Interleukin-27 Functional Duality Balances Leishmania Infectivity and Pathogenesis.

Authors:  Abdollah Jafarzadeh; Maryam Nemati; Prashant Chauhan; Ashok Patidar; Arup Sarkar; Iraj Sharifi; Bhaskar Saha
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

9.  IL-27 amplifies cytokine responses to Gram-negative bacterial products and Salmonella typhimurium infection.

Authors:  C Petes; N Odoardi; S M Plater; N L Martin; K Gee
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379

Review 10.  The Interleukins Orchestrate Mucosal Immune Responses to Salmonella Infection in the Intestine.

Authors:  Fu-Chen Huang
Journal:  Cells       Date:  2021-12-10       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.